Company intelligence / Profile preview

Preclinical GPS

Bainbridge Island, Washington, United Statespreclinicalgps.com ↗

Ownership: Private
Development stage: Other

Overview

Preclinical GPS is a specialized consulting firm that provides tailored drug development strategies, project management, and expert nonclinical guidance for biotech companies. Their expertise spans small molecules, monoclonal antibodies, proteins, and oligonucleotides. They have supported over 45 INDs and more than 1,400 studies—including GLP toxicology studies—and have contributed to multiple NDAs and Phase 2 programs[1][2][4].

Modalities: Small moleculeMonoclonal antibodyProteinOligonucleotide
Industry: Consulting

Beyond the preview

Go deeper on Preclinical GPS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Preclinical GPS.

Explore the full profile